Cargando…
BTLA Expression on Th1, Th2 and Th17 Effector T-Cells of Patients with Systemic Lupus Erythematosus Is Associated with Active Disease
An imbalanced T-cell homeostasis plays an important role in the pathogenesis of systemic lupus erythematosus (SLE). Co-stimulatory and co-inhibitory molecules regulate T-cell differentiation, survival, and cytokine production. B- and T-lymphocyte attenuator (BTLA) is a co-inhibitory molecule which n...
Autores principales: | Oster, Christoph, Wilde, Benjamin, Specker, Christof, Sun, Ming, Kribben, Andreas, Witzke, Oliver, Dolff, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770819/ https://www.ncbi.nlm.nih.gov/pubmed/31514450 http://dx.doi.org/10.3390/ijms20184505 |
Ejemplares similares
-
The Co-inhibitor BTLA Is Functional in ANCA-Associated Vasculitis and Suppresses Th17 Cells
por: Werner, Kai, et al.
Publicado: (2019) -
IL-22 production of effector CD4(+) T-cells is altered in SLE patients
por: Dolff, Sebastian, et al.
Publicado: (2019) -
Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus
por: Dolff, Sebastian, et al.
Publicado: (2010) -
Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected
por: Brinkhoff, Alexandra, et al.
Publicado: (2018) -
Chloroquine Suppresses Effector B-Cell Functions and Has Differential Impact on Regulatory B-Cell Subsets
por: Ma, Xin, et al.
Publicado: (2022)